In addition to breast cancer, SENP1 overexpression has also been implicated in the development of bladder cancer, prostate cancer, neuroblastoma, osteosarcoma, and lung cancer (reviewed in (5)). This evidence concerns the gene SENP1 and Familial prostate cancer.